A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)
Clinical trial NCT07208149 · RECRUITING
Trial details
- NCT number
- NCT07208149
- Sponsor
- Shenzhen Majory Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-29
- Primary completion
- 2028-09-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.